Inventor · disambiguated record
William Matthews
Also filed as: MATTHEWS WILLIAM · MATTHEWS WILLIAM D
15 granted patents·22 pending applications·697 citations·filing 1982–2006
95Inventor score
Top patents by PatentIndex Score
37 records- 0193US6673343B2SAL-S1 receptor protein tyrosine kinase agonist antibodiesGENENTECH INC·Filed 2001·Granted Jan 6, 2004·38 cites·6 claims
- 0293US5851984AMethod of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptidesGENENTECH INC·Filed 1996·Granted Dec 22, 1998·185 cites·20 claims
- 0388US7524937B2WSX receptor agonist antibodiesGENENTECH INC·Filed 2006·Granted Apr 28, 2009·15 cites·18 claims
- 0488US6909031B2Transgenic mice containing glucagon receptor gene disruptionsDELTAGEN INC·Filed 2001·Granted Jun 21, 2005·24 cites·7 claims
- 0588US5624899AMethod for using Htk ligandGENENTECH INC·Filed 1995·Granted Apr 29, 1997·60 cites·2 claims
- 0685US5635177AProtein tyrosine kinase agonist antibodiesGENENTECH INC·Filed 1994·Granted Jun 3, 1997·107 cites·7 claims
- 0784US6159462AUses of Wnt polypeptidesGENENTECH INC·Filed 1997·Granted Dec 12, 2000·75 cites·13 claims
- 0883US4465677APharmaceutical compositions and method of producing alpha2 antagonismSMITHKLINE BECKMAN CORP·Filed 1982·Granted Aug 14, 1984·15 cites·11 claims
- 0982US5864020AHTK ligandGENENTECH INC·Filed 1995·Granted Jan 26, 1999·36 cites·10 claims
- 1081US5635388AAgonist antibodies against the flk2/flt3 receptor and uses thereofGENENTECH INC·Filed 1994·Granted Jun 3, 1997·49 cites·15 claims
- 1179US4496558APharmaceutical compositions and methods for producing alpha antagonismSMITHKLINE BECKMAN CORP·Filed 1983·Granted Jan 29, 1985·12 cites·13 claims
- 1277US6331302B1Protein tyrosine kinase agonist antibodiesGENENTECH INC·Filed 1995·Granted Dec 18, 2001·36 cites·6 claims
- 1373US5997865AAgonist antibodies against the flk2/flt3 receptor and uses thereofFiled 1995·Granted Dec 7, 1999·24 cites·20 claims
- 1462US7074397B1Method for enhancing proliferation or differentiation of a cell using ob proteinGENENTECH INC·Filed 1996·Granted Jul 11, 2006·20 cites·37 claims
- 1557US2005019325A1WSX receptor agonist antibodiesFiled 2004·Application pending·0 cites
- 1655US2005272656A1Method for enhancing proliferation or differentiation of a cell using OB proteinMATTHEWS WILLIAM·Filed 2005·Application pending·0 cites
- 1754US2003004109A1Leptin/ob receptor having a WSX motifFiled 2002·Application pending·0 cites
- 1851US2007074299A1Transgenic Mice Containing GPCR5-1 Gene DisruptionsBRENNAN THOMAS J·Filed 2006·Application pending·0 cites
- 1950US2002177134A1Transgenic mice containing PAFR gene disruptionsFiled 2001·Application pending·0 cites
- 2050US2006143722A1OGR1 gene disruptions, compositions and methods relating theretoBRENNAN THOMAS J·Filed 2006·Application pending·0 cites
- 2149US2006174361A1Transgenic mice containing adrenocorticotropin hormone receptor gene disruptionsALLEN KEITH D·Filed 2006·Application pending·0 cites
- 2249US2006075512A1Transgenic mice containing PAFR gene disruptionsBRENNAN THOMAS J·Filed 2005·Application pending·0 cites
- 2347US2003005473A1OGR1 gene disruptions, compositions and methods relating theretoFiled 2002·Application pending·0 cites
- 2447US2002170081A1Transgenic mice containing GPR31 gene disruptionsFiled 2002·Application pending·0 cites
- 2547US2003018989A1Transgenic mice containing GPCR5-1 gene disruptionsFiled 2002·Application pending·0 cites
- 2645US2006143724A1Transgenic mice containing anaphylatoxin C3a gene disruptionsBRENNAN THOMAS J·Filed 2006·Application pending·0 cites
- 2745US2002133843A1Transgenic mice containing adrenocorticotropin hormone receptor gene disruptionsFiled 2001·Application pending·0 cites
- 2845US2002127712A1Transgenic mice containing anaphylatoxin C3a gene disruptionsFiled 2001·Application pending·0 cites
- 2944US2003014769A1Transgenic mice containing GPCR-like transmembrane protein disruptionsFiled 2002·Application pending·0 cites
- 3042US2006172413A1Transgenic mice containing melanocyte stimulating hormone receptor gene disruptionsALLEN KEITH D·Filed 2006·Application pending·0 cites
- 3142US2002120951A1Transgenic mice containing FPR-RS4 gene disruptionsFiled 2001·Application pending·0 cites
- 3242US2003106073A1Transgenic mice containing FPR-RS4 gene disruptionsFiled 2001·Application pending·0 cites
- 3342US2003167493A1Transgenic mice containing GPRC5B-like gene disruptionsFiled 2001·Application pending·0 cites
- 3441US2002088012A1Transgenic mice containing lymphoid-specific GPCR gene disruptionsFiled 2001·Application pending·0 cites
- 3539US2002038467A1Transgenic mice containing melanocyte stimulating hormone receptor gene disruptionsFiled 2001·Application pending·0 cites
- 3637US6541604B1Leptin receptor having a WSX motifGENENTECH INC·Filed 1997·Granted Apr 1, 2003·1 cites·1 claims
- 3726US2002193571A1Wsx receptor agonist antibodiesFiled 1997·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William Matthews files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →